SCHEMBL753045

SCHEMBL753045

C[C@H](c1ccc(Oc2ccc(C(=O)O)c(F)c2)cc1Cl)[C@@](O)(c1ccc(=O)n(C)c1)C(F)(F)F

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX3 P56373 1/20 0.34
S1PR2 O95136 2/20 0.33
SCN8A Q9UQD0 1/20 0.33
SCN10A Q9Y5Y9 1/20 0.33
CYP11B1 P15538 2/20 0.31
CYP11B2 P19099 2/20 0.31
NR3C1 P04150 2/20 0.31
FFAR1 O14842 2/20 0.31
MEN1 O00255 1/20 0.31
TTR P02766 1/20 0.31
PPOX P50336 1/20 0.31
KMT2A Q03164 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
PTGER4 P35408 1/20 0.31
SCN9A Q15858 3/20 0.31
F11 P03951 1/20 0.31
KLKB1 P03952 1/20 0.31
CYP2C9 P11712 1/20 0.31
KCNH2 Q12809 1/20 0.31
CACNA1C Q13936 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL733267 1.00 P2RX3 (0.34) P2RX3S1PR2SCN8ASCN10ACYP11B1
SCHEMBL734909 0.94 S1PR2 (0.34) S1PR2SCN8ASCN10ANR3C1FFAR1
SCHEMBL754450 0.94 S1PR2 (0.34) S1PR2SCN8ASCN10ANR3C1FFAR1
SCHEMBL732524 0.93 P2RX3 (0.34) P2RX3S1PR2SCN8ASCN10ACYP11B1
SCHEMBL754912 0.93 P2RX3 (0.34) P2RX3S1PR2SCN8ASCN10ACYP11B1
SCHEMBL754534 0.91 SCN8A (0.35) P2RX3SCN8ASCN10ANR3C1FFAR1
SCHEMBL733289 0.91 SCN8A (0.35) P2RX3SCN8ASCN10ANR3C1FFAR1
SCHEMBL480763 0.91 KCNH2 (0.35) S1PR2SCN8ASCN10AMEN1TTR
SCHEMBL754543 0.91 KCNH2 (0.35) S1PR2SCN8ASCN10AMEN1TTR
SCHEMBL733103 0.90 SCN8A (0.35) P2RX3S1PR2SCN8ASCN10ACYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 P2RX3 696/4885S1PR2 548/4885SCN8A 2137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.